Avadel Pharmaceuticals PLC (STU:AWK)
€ 9.85 0.4 (4.23%) Market Cap: 949.15 Mil Enterprise Value: 888.38 Mil PE Ratio: 0 PB Ratio: 13.32 GF Score: 40/100

Avadel Pharmaceuticals PLC at Needham Healthcare Conference (Virtual) Transcript

Apr 17, 2023 / 01:30PM GMT
Release Date Price: €8.9 (-2.20%)
Ami Fadia
Needham & Company, LLC - Analyst

Good morning, everyone. Again, thanks for joining us for the next session. I'm Ami Fadia. I'm one of the biotech analysts here at Needham. It's my pleasure to be hosting the Avadel team for this session. Greg, Tom, Richard, thank you so much for joining us today.

Maybe what I'll do is start by requesting Greg to just kick it off with overview of kind of the recent updates to the company. You had the recent sort of financing as well as the upcoming decision from the FDA. So, if you could just sort of level set for listeners where we are. And then we'll jump to Q&A. (Conference instructions) With that, turn over to you, Greg.

Greg Divis
Avadel Pharmaceuticals plc - CEO

Thanks, Ami. And as always, thank you for the opportunity to participate and be a part of this conference. Maybe I'll just start with the general commentary that some of our comments today may include forward-looking statements. And to the extent they do in our business is subject to risks and uncertainties that are described in our 10

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot